003020 立方製藥
按盤價 
24.200 +0.150 (+0.624%)
24.200 +0.150 (+0.624%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.786 | 14.322 | 15.033 | 13.901 | 15.320 |
| 總資產報酬率 ROA (%) | 1.220 | 9.844 | 11.025 | 10.729 | 11.140 |
| 投入資產回報率 ROIC (%) | 1.721 | 12.952 | 13.104 | 12.281 | 9.914 | 邊際利潤分析 |
| 銷售毛利率 (%) | 69.007 | 51.483 | 37.385 | 39.906 | 33.450 |
| 營業利潤率 (%) | 8.697 | 13.430 | 9.307 | 8.466 | 8.311 |
| 息稅前利潤/營業總收入 (%) | 8.563 | 13.369 | 9.160 | 8.500 | 8.111 |
| 淨利潤/營業總收入 (%) | 8.230 | 12.304 | 8.112 | 7.576 | 7.133 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 89.131 | 84.758 | 84.453 | 90.612 | 94.550 |
| 價值變動淨收益/利潤總額(%) | 15.189 | 10.800 | 13.449 | 5.761 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -0.023 | 0.834 | -0.097 | 1.222 | -0.317 | 償債能力分析 |
| 流動比率 (X) | 2.190 | 2.121 | 2.333 | 3.718 | 3.774 |
| 速動比率 (X) | 1.746 | 1.673 | 1.752 | 3.142 | 3.208 |
| 資產負債率 (%) | 23.475 | 24.568 | 30.241 | 22.129 | 23.569 |
| 帶息債務/全部投入資本 (%) | 1.831 | 1.493 | 14.462 | 6.599 | -- |
| 股東權益/帶息債務 (%) | 5,257.955 | 6,459.033 | 584.027 | 1,370.653 | 692.723 |
| 股東權益/負債合計 (%) | 292.877 | 276.234 | 230.675 | 351.900 | 324.284 |
| 利息保障倍數 (X) | -64.781 | -77.149 | -66.620 | -120.756 | -46.707 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 72.923 | 54.865 | 42.121 | 40.994 | 0.000 |
| 存貨周轉天數 (天) | 206.315 | 118.024 | 61.367 | 50.420 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 21/05/2024 16:05 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
